Intellia Therapeutics, Inc.

NTLA · Healthcare · · USD

12.74 USD

+0.00 (0.47%)

● Updated 2026-09-07 20:38 Saudi Time ↻ Refresh

Short-term Mid-term Long-term

Fahodi Score HOLD Mid-term (Position)

/ 100

Technical 75

Trend & RS 73

Momentum 51

Fundamental 22

Macro 64

Liquidity 30

Component	Score	Weight
Technical	75.0	20%
Trend & RS	72.6	30%
Momentum	50.7	15%
Fundamental	22.2	10%
Macro	64.4	20%
Liquidity	29.5	5%

Trade Setup

Entry	12.74
Stop Loss	11.38 (10.7%)
Target 1 (1:1)	14.10 (+10.7%)
Target 2 (2:1)	15.46 (+21.4%)

ATR(14)	0.68 (5.3%)
Risk per Share	1.36
Reward:Risk	2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor	Score	Z
Value	79.5	+1.18
Momentum	50.7	+0.03
Quality	40.0	-0.40
Composite	56.7

Quality Scores

Piotroski F-Score 2 /9 — Weak

✗ ✗ ✗ ✗ ✓ ✓ ✗ ✗ ✗

1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover

Altman Z-Score Insufficient Data

Valuation vs Peers Undervalued

Metric	Stock	Sector	vs Peers
P/E Ratio	N/A	22.0	Inline
P/B Ratio	2.5	4.0	Below

Comparing against Healthcare median multiples.

Trading at a discount to sector peers — potential value opportunity.

Position Sizing — Kelly Criterion

4.5%

Recommended Size

40.1%

Full Kelly

20.05%

Half Kelly

5.0%

Max Cap (Moderate)

Kelly inputs derived from quant score 61/100. Estimated win rate 58%, avg win 8.7%, avg loss 3.8%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

BEAR Regime: BEAR (20% confidence) — position size reduced 10%

Signal Summary STRONG BUY

Bullish Signals

Bearish Signals

52.15

RSI(14)

0.1357

MACD

Relative Strength (RS) WEAKENING

/ 99

RS Rating

✓ O'Neil PASS (≥80)

RS vs SPY	↓ FALLING (-10.6% vs SPY 3M)
RS vs Sector	UNDERPERFORMING (Healthcare)
RS New High	No (44d since high)
Sector Outperformance	-13.7% (3M)

RS Line — stock / SPY (90 bars)

← older newer →

RS vs SPY 50-day SMA of RS

WEAKENING: Losing momentum — the stock was performing well but is now falling behind the market.

Technical Indicators

Indicator	Value	Signal
Rsi	52.15	NEUTRAL
Macd	0.1357	BULLISH
Ma Cross	12.92 / 12.55	GOLDEN CROSS
Trend Short		BELOW SMA50
Trend Long		ABOVE SMA200
Bollinger		MIDDLE
Volume	0.9x	NORMAL

Key Levels

Level	Price
52-Week High	28.25
Bollinger Upper	13.61
SMA(200)	12.55
SMA(50)	12.92
SMA(20)	12.55
Current Price	12.74
Bollinger Lower	11.49
52-Week Low	7.95
ATR(14)	0.68

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

ACCUMULATION B Confidence

67%

Volume Dry-Up (Accumulation)

Acc: 2.0 | Dist: 1.0 | Markup: 0.0 | Markdown: 0.0

Volume Spread Analysis (last 5 bars)

Date	Signal	Vol	Description
2026-08-31	Normal	0.94x	Normal bar — no special VSA pattern
2026-09-01	Normal	0.7x	Normal bar — no special VSA pattern
2026-09-02	Normal	1.05x	Normal bar — no special VSA pattern
2026-09-03	Normal	0.97x	Normal bar — no special VSA pattern
2026-09-04	Normal	0.9x	Normal bar — no special VSA pattern

Ichimoku Cloud NEUTRAL

Line	Value	Status
Tenkan-sen (9)	13.00	Above Kijun
Kijun-sen (26)	12.07	Base line
Senkou A	12.54	Leading span A
Senkou B	14.32	Leading span B
Cloud	12.54 – 14.32	Bearish (Red)
Price vs Cloud	12.74	Inside Cloud
Chikou Span	10.68	Bullish
Alignment Score	2/4	NEUTRAL